Quality of life after treatment of neuroendocrine liver metastasis

A large subset of patients with neuroendocrine liver metastasis (NELM) is symptomatic at the time of presentation. In addition to improving survival, treatment of NELM seeks to provide palliation of symptoms. However, data on health-related quality of life (QoL) are uncommon. We sought to define patient-reported QoL after treatment of NELM.Patients who underwent treatment of NELM at Johns Hopkins Hospital between 1998 and 2013 and who were alive...